Validation of the Bullying Scale for Adults - Results of the PRONIA-study.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 12 2019
revised: 05 03 2020
accepted: 17 04 2020
pubmed: 6 7 2020
medline: 15 5 2021
entrez: 6 7 2020
Statut: ppublish

Résumé

Bullying as a specific subtype of adverse life events is a major risk factor for poor mental health. Although many questionnaires on bullying are available, so far none covers bullying retrospectively throughout school and working life. To close this gap, the Bullying Scale for Adults (BSA) was designed. Based on data of 622 participants from five European countries collected in the prospective multicenter Personalized Prognostic Tools for Early Psychosis Management (PRONIA) study, we investigated whether the BSA is a reliable and valid measurement for bullying and whether there is a difference across different diagnostic groups of early mental disorders (recent onset depressive/ psychotic patients, patients at clinical high-risk of psychosis) and healthy controls. Bullying experiences were significantly less frequent in healthy controls than in patient groups, with no significant differences between the three clinical groups. The BSA exhibited a high item scale discrimination (r > .3) and very good internal consistency (Cronbach's α = .93). Four factors were identified: 1. Sexual harassment, 2. Emotional Abuse, 3. Physical Abuse, 4. Problems at school. The highly significant correlation between bullying, and childhood adversities and trauma (r = .645, p < .001) indicated good concurrent validity. The BSA is the first validated questionnaire that, in retrospective, reliably records various aspects of bullying (incl. its consequences) not only throughout childhood but also working life. It can be used to assess bullying as a transdiagnostic risk factor of mental disorders in different mental disorders, esp. psychosis and depression.

Sections du résumé

BACKGROUND
Bullying as a specific subtype of adverse life events is a major risk factor for poor mental health. Although many questionnaires on bullying are available, so far none covers bullying retrospectively throughout school and working life. To close this gap, the Bullying Scale for Adults (BSA) was designed.
METHODS
Based on data of 622 participants from five European countries collected in the prospective multicenter Personalized Prognostic Tools for Early Psychosis Management (PRONIA) study, we investigated whether the BSA is a reliable and valid measurement for bullying and whether there is a difference across different diagnostic groups of early mental disorders (recent onset depressive/ psychotic patients, patients at clinical high-risk of psychosis) and healthy controls.
RESULTS
Bullying experiences were significantly less frequent in healthy controls than in patient groups, with no significant differences between the three clinical groups. The BSA exhibited a high item scale discrimination (r > .3) and very good internal consistency (Cronbach's α = .93). Four factors were identified: 1. Sexual harassment, 2. Emotional Abuse, 3. Physical Abuse, 4. Problems at school. The highly significant correlation between bullying, and childhood adversities and trauma (r = .645, p < .001) indicated good concurrent validity.
DISCUSSION
The BSA is the first validated questionnaire that, in retrospective, reliably records various aspects of bullying (incl. its consequences) not only throughout childhood but also working life. It can be used to assess bullying as a transdiagnostic risk factor of mental disorders in different mental disorders, esp. psychosis and depression.

Identifiants

pubmed: 32623026
pii: S0022-3956(19)31431-1
doi: 10.1016/j.jpsychires.2020.04.004
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-97

Investigateurs

Linda Betz (L)
Anne Erkens (A)
Eva Gussmann (E)
Shalaila Haas (S)
Alkomiet Hasan (A)
Claudius Hoff (C)
Ifrah Khanya-Ree (I)
Aylin Melo (A)
Susanna Muckenhuber-Sternbauer (S)
Janis Köhler (J)
Ömer Öztürk (Ö)
Nora Penzel (N)
David Popovic (D)
Adrian Rangnick (A)
Sebastian von Saldern (S)
Rachele Sanfelici (R)
Moritz Spangemacher (M)
Ana Tupac (A)
Maria Fernanda Urquijo (MF)
Johanna Weiske (J)
Antonia Wosgien (A)
Dennis Hedderich (D)
Karsten Blume (K)
Christiane Woopen (C)
Christina Andreou (C)
Laura Egloff (L)
Fabienne Harrisberger (F)
Claudia Lenz (C)
Letizia Leanza (L)
Amatya Mackin-Tosh (A)
Renata Smieskova (R)
Erich Studerus (E)
Anna Walter (A)
Sonja Widmayer (S)
Chris Day (C)
Sian Lowri Griffiths (SL)
Mariam Iqbal (M)
Mirabel Pelton (M)
Pavan Mallikarjun (P)
Alexandra Stainton (A)
Ashleigh Lin (A)
Alexander Denissoff (A)
Anu Ellilä (A)
Tiina From (T)
Markus Heinimaa (M)
Tuula Ilonen (T)
Päivi Jalo (P)
Heikki Lauri-Kainen (H)
Antti Luutonen (A)
Akseli Mäkela (A)
Janina Paju (J)
Henri Pesonen (H)
Reetta-Liina Armio (RL)
Anna Toivonen (A)
Otto Turtonen (O)
Ana Beatriz Solana (AB)
Manuela Abraham (M)
Nicolas Hehn (N)
Timo Schirmer (T)
Carlo Altamura (C)
Marika Belleri (M)
Francesca Bottinelli (F)
Adele Ferro (A)
Marta Re (M)
Emiliano Monzani (E)
Mauro Percudani (M)
Maurizio Sberna (M)
Armando D'Agostino (A)
Lorenzo Del Fabro (L)
Giampaolo Perna (G)
Maria Nobile (M)
Alessandra Alciati (A)
Matteo Balestrieri (M)
Carolina Bonivento (C)
Giuseppe Cabras (G)
Franco Fabbro (F)
Marco Garzitto (M)
Sara Piccin (S)

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Theresa Katharina Haidl (TK)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany. Electronic address: theresa.haidl@uk-koeln.de.

Nicole Schneider (N)

Department of Clinical Psychology and Psychotherapy, University of Cologne, Cologne, Germany.

Kim Dickmann (K)

Department of Clinical Psychology and Psychotherapy, University of Cologne, Cologne, Germany.

Stephan Ruhrmann (S)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Nathalie Kaiser (N)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Marlene Rosen (M)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Mauro Seves (M)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Thorsten Lichtenstein (T)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Rachel Upthegrove (R)

Institute of Mental Health & School of Psychology, University of Birmingham, United Kingdom.

Raimo K R Salokangas (RKR)

Department of Psychiatry, University of Turku, Finland.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, University of Melbourne & Melbourne Health, Australia.

Eva Meisenzahl (E)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Stephen J Wood (SJ)

Institute of Mental Health & School of Psychology, University of Birmingham, United Kingdom; Orygen, the National Centre of Excellence for Youth Mental Health, Melbourne, Australia; Centre for Youth Mental Health, University of Melbourne, Australia.

Paolo Brambilla (P)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Stefan Borgwardt (S)

Department of Psychiatry (Psychiatric University Hospital, UPK), University of Basel, Switzerland; Department of Psychiatry and Psychotherapy, University of Lübeck, Germany.

Lencer Rebekka (L)

Department of Psychiatry and Psychotherapy, Westfälische-Wilhelms-University Münster, Münster, Germany.

Joseph Kambeitz (J)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Nikolaos Koutsouleris (N)

Department of Psychiatry and Psychotherapy, Ludwig-Maximillians-University Munich, Munich, Germany.

Frauke Schultze-Lutter (F)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH